G6PD and neuromyelitis optica: Vitamin D, used in MS treatment, can increase the activity and the production of G6PD.12-14 This can possibly explain the protective impact of vitamin D against oxidative stress.15 Considering G6PD’s protective role against oxidative damage as well as its role in myelin production, its deficiency may exist in MS and NMO.